Posts tagged Vertex

Hepatitis C research is among the fastest moving industry sectors as medications hailed as game-changes just two years ago are being trumped by newer therapeutics in the pipeline. Some physicians are telling HCV patients to wait for the newer drugs, while others say patients should be treated immediately with what is already available.

Hepatitis C research is among the fastest moving industry sectors as medications hailed as game-changes just two years ago are being trumped by newer therapeutics in the pipeline. Some physicians are telling HCV patients to wait for the newer drugs, while others say patients should be treated immediately with what is already available.

Rival hepatitis C drugs from Merck & Co and Vertex Pharmaceuticals are effective in patients also infected with HIV, the virus that causes AIDS, according to data released on Tuesday. The Vertex drug had the more impressive results, the data showed.

Rival hepatitis C drugs from Merck & Co and Vertex Pharmaceuticals are effective in patients also infected with HIV, the virus that causes AIDS, according to data released on Tuesday. The Vertex drug had the more impressive results, the data showed.

Market for hepatitis C drug companies remains in play. Idenix Pharmaceuticals is the latest developer of hepatitis C drugs in the news. In the last two months alone, two other developers of hepatitis C drugs have been scooped up in multibillion-dollar deals, stoking speculation that the 14-year-old Cambridge company may be next in line.

New Hepatitis C Drugs Create Unique Opportunities, Challenges

The dust is starting to settle following FDA’s approval last month of Merck’s Victrelis (boceprevir) and Incivek (telaprevir) by Vertex – the two new breakthrough protease inhibitors for hepatitis C. Read more in the Specialty Pharma Journal